Format

Send to

Choose Destination
Ann N Y Acad Sci. 2009 Dec;1182:69-79. doi: 10.1111/j.1749-6632.2009.05069.x.

Clinical Use of Interferon-gamma.

Author information

1
Center for Cancer Research, Cancer and Inflammation Program, Laboratory of Experimental Immunology, National Cancer Institute-Frederick, Frederick, Maryland 21702, USA.

Abstract

Interferon gamma (IFN-gamma), a pleotropic cytokine, has been shown to be important to the function of virtually all immune cells and both innate and adaptive immune responses. In 1986, early clinical trials of this cytokine began to evaluate its therapeutic potential. The initial studies focused on the tolerability and pharmacology of IFN-gamma and systematically determined its antitumor and anti-infection activities. In the 20-plus years since those first trials, IFN-gamma has been used in a wide variety of clinical indications, which are reviewed in this article.

PMID:
20074276
PMCID:
PMC6574079
DOI:
10.1111/j.1749-6632.2009.05069.x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center